MLTX logo

MoonLake Immunotherapeutics (MLTX) EV/EBITDA

EV/EBITDA:

-1.98-0.10(-5.32%)
November 7, 2025

Summary

  • As of today, MLTX EV/EBITDA is -1.98, with a fall of -0.10 (-5.32%) during the most recent trading session on November 7, 2025.
  • Over the past year, MLTX EV/EBITDA has increased by +22.96 (+92.06%).
  • MLTX EV/EBITDA is now -725.00% below its all-time high of -0.24.

Performance

MLTX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherMLTXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

MLTX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise ValueEnterprise ValuePricePrice
1D1 Day-5.3%+5.7%+3.3%
1M1 Month-55.9%+56.5%+14.6%
3M3 Months+86.7%-84.8%-79.5%
6M6 Months+83.1%-77.4%-71.7%
YTDYTD+90.5%-84.9%-80.4%
1Y1 Year+92.1%-83.4%-79.0%
5Y5 Years-+265.1%+3.3%

MLTX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month-1.22-62.3%-1.98at low
3M3-Month-0.24-725.0%-18.08+89.0%
6M6-Month-0.24-725.0%-18.08+89.0%
1Y1-Year-0.24-725.0%-28.21+93.0%
3Y3-Year-0.24-725.0%-61.99+96.8%
5Y5-Year-0.24-725.0%-1492+99.9%
All-TimeAll-Time-0.24-725.0%-1492+99.9%

MLTX EV/EBITDA History

DateValue
2025
-1.98(+90.6%)
2024
-20.96(+63.9%)
2023
-58.11(-1019.7%)
DateValue
2022
-5.19(-121.8%)
2021
-2.34(+99.8%)
2020
-1333.00

FAQ

  • What is MoonLake Immunotherapeutics EV/EBITDA?
  • What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
  • What is MLTX EV/EBITDA year-to-date change?
  • What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

What is MoonLake Immunotherapeutics EV/EBITDA?

The current EV/EBITDA of MLTX is -1.98

What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high EV/EBITDA is -0.24

What is MLTX EV/EBITDA year-to-date change?

MoonLake Immunotherapeutics EV/EBITDA has changed by +18.98 (+90.55%) since the beginning of the year

What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?

Over the past year, MLTX EV/EBITDA has changed by +22.96 (+92.06%)
On this page